A novel web-based online nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome.

J Transl Autoimmun · 2023 · PMC10590873 · PMID 37877134

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

a barely detectable statistically significant differenceP = 0.073so close (0.05 < p ≤ 0.1)

The AUC of APOSF-nomogram for predicting advanced fibrosis was 0.845 (95 % confidence interval [CI]: 0.754–0.936) in the development set which was significantly better than APRI (0.714, 95%CI: 0.598–0.830, P = 0.011) and a barely detectable statistically significant difference was found compared with FIB-4 (0.768, 95%CI: 0.651–0.884, P = 0.073).

also in 4 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.